{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:01:24Z","timestamp":1756382484045},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2481-y","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T13:02:46Z","timestamp":1498136566000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A case report of septic shock syndrome caused by S. pneumoniae in an immunocompromised patient despite of vaccination"],"prefix":"10.1186","volume":"17","author":[{"given":"Josef","family":"Singer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Testori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schellongowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammon","family":"Handisurya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva-Maria","family":"Reitter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Graninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Kn\u00f6bl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Staudinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Thalhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"issue":"2","key":"2481_CR1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2213-2600(13)70165-6","volume":"2","author":"CL Krone","year":"2014","unstructured":"Krone CL, van de Groep K, Trzcinski K, Sanders EA, Bogaert D. Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions. Lancet Respir med. 2014;2(2):141\u201353.","journal-title":"Lancet Respir med"},{"issue":"6","key":"2481_CR2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11882-010-0139-6","volume":"10","author":"MS Benninger","year":"2010","unstructured":"Benninger MS, Manz R. The impact of vaccination on rhinosinusitis and otitis media. Curr Allergy Asthma rep. 2010;10(6):411\u20138.","journal-title":"Curr Allergy Asthma rep"},{"issue":"4","key":"2481_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3947\/ic.2013.45.4.351","volume":"45","author":"JY Song","year":"2013","unstructured":"Song JY, Eun BW, Nahm MH. Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward. Infect Chemother. 2013;45(4):351\u201366.","journal-title":"Infect Chemother"},{"issue":"1","key":"2481_CR4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3346\/jkms.2013.28.1.4","volume":"28","author":"JY Song","year":"2013","unstructured":"Song JY, Nahm MH, Moseley MA. Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance. J Korean med Sci. 2013;28(1):4\u201315.","journal-title":"J Korean med Sci"},{"issue":"10","key":"2481_CR5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1586\/14787210.2013.839381","volume":"11","author":"R Nau","year":"2013","unstructured":"Nau R, Djukic M, Spreer A, Eiffert H. Bacterial meningitis: new therapeutic approaches. Expert rev Anti-Infect Ther. 2013;11(10):1079\u201395.","journal-title":"Expert rev Anti-Infect Ther"},{"key":"2481_CR6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/1471-2334-13-492","volume":"13","author":"J Ahl","year":"2013","unstructured":"Ahl J, Littorin N, Forsgren A, Odenholt I, Resman F, Riesbeck K. High incidence of septic shock caused by Streptococcus Pneumoniae serotype 3--a retrospective epidemiological study. BMC Infect dis. 2013;13:492.","journal-title":"BMC Infect dis"},{"issue":"8","key":"2481_CR7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1586\/erv.11.99","volume":"10","author":"DS Fedson","year":"2011","unstructured":"Fedson DS, Nicolas-Spony L, Klemets P, et al. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert rev Vaccines. 2011;10(8):1143\u201367.","journal-title":"Expert rev Vaccines"},{"key":"2481_CR8","unstructured":"Impfplan \u00d6sterreich 2015. Available at: \nhttp:\/\/bmg.gv.at\/cms\/home\/attachments\/8\/9\/4\/CH1100\/CMS1389365860013\/impfplan.pdf\n\n."},{"issue":"1","key":"2481_CR9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect dis. 2000;30(1):100\u201321.","journal-title":"Clin Infect dis"},{"issue":"4","key":"2481_CR10","first-page":"309","volume":"69","author":"C Feldman","year":"2014","unstructured":"Feldman C, Anderson R. Review: current and new generation pneumococcal vaccines. J Inf Secur. 2014;69(4):309\u201325.","journal-title":"J Inf Secur"},{"issue":"37","key":"2481_CR11","first-page":"822","volume":"63","author":"S Tomczyk","year":"2014","unstructured":"Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >\/=65 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly rep. 2014;63(37):822\u20135.","journal-title":"MMWR Morb Mortal Wkly rep"},{"issue":"4 Pt 1","key":"2481_CR12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1542\/peds.101.4.604","volume":"101","author":"MB Rennels","year":"1998","unstructured":"Rennels MB, Edwards KM, Keyserling HL, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics. 1998;101(4 Pt 1):604\u201311.","journal-title":"Pediatrics"},{"issue":"5","key":"2481_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/11202760-000000000-00000","volume":"11","author":"JD Croxtall","year":"2009","unstructured":"Croxtall JD, Keating GM. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). Paediatr Drugs. 2009;11(5):349\u201357.","journal-title":"Paediatr Drugs"},{"issue":"15","key":"2481_CR14","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2165\/11205110-000000000-00000","volume":"70","author":"ST Duggan","year":"2010","unstructured":"Duggan ST. Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13(R)]. Drugs. 2010;70(15):1973\u201386.","journal-title":"Drugs"},{"issue":"3","key":"2481_CR15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","volume":"4","author":"D Bogaert","year":"2004","unstructured":"Bogaert D, De Groot R, Hermans PW. Streptococcus Pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect dis. 2004;4(3):144\u201354.","journal-title":"Lancet Infect dis"},{"key":"2481_CR16","unstructured":"Jahresbericht 2009. Available at: \nhttp:\/\/www.bmg.gv.at\/cms\/home\/attachments\/2\/0\/5\/CH1187\/CMS1287138906294\/pneumokokken_30082010.pdf\n\n. Accessed 8 June 2017."},{"key":"2481_CR17","unstructured":"Jahresbericht 2011. Available at: \nhttp:\/\/www.bmgf.gv.at\/cms\/home\/attachments\/2\/5\/7\/CH1338\/CMS1347361198386\/pneumokokken-jb_2011_final_24082012.pdf\n\n. Accessed 8 June 2017."},{"key":"2481_CR18","unstructured":"Jahresbericht 2012. Available at: \nhttp:\/\/www.bmgf.gv.at\/cms\/home\/attachments\/3\/4\/4\/CH1400\/CMS1363097003492\/pneumokokken_jahresbericht-final_-_03042013.pdf\n\n. Accessed 8 June 2017."},{"issue":"1","key":"2481_CR19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect dis. 2000;30(1):122\u201340.","journal-title":"Clin Infect dis"},{"issue":"1","key":"2481_CR20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12916-016-0755-7","volume":"14","author":"A Alari","year":"2016","unstructured":"Alari A, Chaussade H, Domenech De Celles M, et al. Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis. BMC Med. 2016;14(1):211.","journal-title":"BMC Med"},{"key":"2481_CR21","first-page":"65","volume":"3","author":"VK Rao","year":"2015","unstructured":"Rao VK. Approaches to managing autoimmune Cytopenias in novel immunological disorders with genetic underpinnings like autoimmune Lymphoproliferative syndrome. Front Pediatr. 2015;3:65.","journal-title":"Front Pediatr"},{"issue":"13","key":"2481_CR22","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","volume":"123","author":"S Price","year":"2014","unstructured":"Price S, Shaw PA, Seitz A, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014;123(13):1989\u201399.","journal-title":"Blood"},{"issue":"22","key":"2481_CR23","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1182\/blood-2011-07-325217","volume":"118","author":"VK Rao","year":"2011","unstructured":"Rao VK, Oliveira JB. How I treat autoimmune lymphoproliferative syndrome. Blood. 2011;118(22):5741\u201351.","journal-title":"Blood"},{"issue":"9","key":"2481_CR24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s11882-014-0462-4","volume":"14","author":"S Shah","year":"2014","unstructured":"Shah S, Wu E, Rao VK, Tarrant TK. Autoimmune lymphoproliferative syndrome: an update and review of the literature. Curr Allergy Asthma rep. 2014;14(9):462.","journal-title":"Curr Allergy Asthma rep"},{"issue":"1","key":"2481_CR25","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2015.057","volume":"7","author":"G Leone","year":"2015","unstructured":"Leone G, Pizzigallo E. Bacterial infections following Splenectomy for malignant and nonmalignant hematologic diseases. Mediterr J Hematol Infect dis. 2015;7(1):e2015057.","journal-title":"Mediterr J Hematol Infect dis"},{"issue":"1","key":"2481_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOP.0b013e32834ea739","volume":"24","author":"DT Teachey","year":"2012","unstructured":"Teachey DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr. 2012;24(1):1\u20138.","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"2481_CR27","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0022-3476(95)70369-1","volume":"126","author":"GE Rivard","year":"1995","unstructured":"Rivard GE, David M, Farrell C, Schwarz HP. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr. 1995;126(4):646\u201352.","journal-title":"J Pediatr"},{"issue":"6","key":"2481_CR28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1358\/dot.2008.44.6.1223894","volume":"44","author":"PN Knoebl","year":"2008","unstructured":"Knoebl PN. Human protein C concentrates for replacement therapy in congenital and acquired protein C deficiency. Drugs Today (Barc). 2008;44(6):429\u201341.","journal-title":"Drugs Today (Barc)"},{"issue":"3","key":"2481_CR29","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1172\/JCI112902","volume":"79","author":"FB Taylor Jr","year":"1987","unstructured":"Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987;79(3):918\u201325.","journal-title":"J Clin Invest"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T13:02:58Z","timestamp":1498136578000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2481-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2481"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2481-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]},"article-number":"442"}}